Stock Market

Biotech Stocks with Pessimistic Trend: Halozyme Therapeutics, Inc …

If there is such a thing as a poster child for volatility in the stock market, the biotech sector would likely take top honors.Biotech stocks are unique. While stocks in other sectors are typically valued based on their past performance and future earnings potential, the majority of biotech stocks don’t have a cent in recurring revenue. Instead, biotech stocks are […]

Biotech Stock News (INO) (AZN) (IMUC) (AAVL) – CNA Finance

Inovio Pharmaceuticals (NASDAQ:INO)On August 10, 2015 shares of Inovio were up about 25% after the company announced a partnership deal with a big pharmaceutical company known as AstraZeneca (NYSE:AZN)Although one key thing to note here is that this deal is being established with MedImmune specifically, but it is the research and development arm for AstraZeneca. With this deal established AstraZeneca […]

Biotech Stocks Buzz: Radius Health Inc (NASDAQ:RDUS), Agenus …

If there is such a thing as a poster child for volatility in the stock market, the biotech sector would likely take top honors.Biotech stocks are unique. While stocks in other sectors are typically valued based on their past performance and future earnings potential, the majority of biotech stocks don’t have a cent in recurring revenue. Instead, biotech stocks are […]

Aquinox Pharmaceuticals Inc (AQXP): How This Biotech Stock …

David Zeiler:  For biotech stock investors, what happened to Aquanox Pharmaceuticals Inc. (NASDAQ:AQXP) over the past week looked like the ultimate fantasy come true.After reporting positive results from a mid-stage test for its bladder pain syndrome/interstitial cystitis drug AQX-1125 on Aug. 7, Aquanox stock took off like a rocket.Have you ever wondered how billionaires continue to get RICHER, while the rest of the world is struggling?“I study […]

Three Biotech Stocks Are Tumbling: Cytori Therapeutics Inc (CYTX …

If there is such a thing as a poster child for volatility in the stock market, the biotech sector would likely take top honors.Biotech stocks are unique. While stocks in other sectors are typically valued based on their past performance and future earnings potential, the majority of biotech stocks don’t have a cent in recurring revenue. Instead, biotech stocks are […]

Harness Biotech Stock Volatility with an Options Strategy :: The …

Harness Biotech Stock Volatility with an Options StrategyCompanies / BioTechAug 13, 2015 – 10:27 PM GMTBy: TLSReportVolatility is the nature of the biotech beast, and it must be tamed or utilized to advantage. That’s the philosophy of Eden Rahim, portfolio manager and option strategist at Theta Strategies Capital. Can you grow a portfolio if some of your more successful names […]

Top Oversold Biotech Stocks Include Mylan (NASDAQ: MYL …

With many investors starting to get more scared about China, scared about Europe and even scared about the coming interest rate hike cycle from the Federal Reserve, some smart money investors may be trying to figure out which stocks have already been heavily discounted to factor in bad news already. It may be impossible to ever know if a true […]

Pipeline Updates Make These Three Biotech Stocks … – Benzinga

Related ICPTCNBC’s Meg Tirrel Speculates About Gilead’s New AcquisitonHow Wedbush’s Liana Moussatos Is Trading These Biopharma StocksShaken, Not Stirred: Is The ‘Biotech Bubble’ Beginning To Burst?(Seeking Alpha)Related Sarepta Therapeutics Announces New England Journal of Medicine Publication of Phase I Clinical Data of Marburg Drug Candidate, AVI-7288, Supporting Safety of the PMOplus® platformShort-Sellers Betting Against These BiotechsSarepta Posts Narrower-than-Expected Loss in […]

These are the Biggest Risk to Biotech – Stocks to Watch – Barrons.com

By Ben LevisohnIn a note this morning, BofA Merrill Lynch’s Christina Giannini and team note that the risk for big-cap biotech stocks–think Gilead Sciences (GILD) and Biogen (BIIB)–and small-cap biotech stocks–everything else–are quite different. They explain:
Associated Press

Biotech is now more passive than actively managed: Perhaps due to the difficulty picking stocks within such an idiosyncratic sector given the complicated science […]

Biotech Stock Roundup: Biogen Down on Tecfidera Issues – Zacks …

Several major biotech companies like Biogen (BIIB – Analyst Report), AbbVie (ABBV – Analyst Report), Celgene and Gilead reported second quarter results over the last five trading days. Biogen has been grabbing headlines for the wrong reasons – although the company’s earnings were better-than-expected, revenues missed expectations.With the company saying that it is cutting its outlook based on revised expectations […]